Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
pembrolizumab
×
CNS
×
Clear all
Filters
3
NCT03797326
2025-11-17
LEAP-005
Merck Sharp & Dohme LLC
Phase 2
Completed
611 enrolled
27 charts
NCT05235737
2023-08-31
PIRG
Medical University of Silesia
Phase 4
Recruiting
36 enrolled